DK1343013T3 - Fremgangsmåder til screening af forbindelser der modulerer apoptose, forbindelser der er identificeret ved fremgangsmåderne, og anvendelse af forbindelserne som terapeutiske midler - Google Patents
Fremgangsmåder til screening af forbindelser der modulerer apoptose, forbindelser der er identificeret ved fremgangsmåderne, og anvendelse af forbindelserne som terapeutiske midlerInfo
- Publication number
- DK1343013T3 DK1343013T3 DK02290578T DK02290578T DK1343013T3 DK 1343013 T3 DK1343013 T3 DK 1343013T3 DK 02290578 T DK02290578 T DK 02290578T DK 02290578 T DK02290578 T DK 02290578T DK 1343013 T3 DK1343013 T3 DK 1343013T3
- Authority
- DK
- Denmark
- Prior art keywords
- compounds
- methods
- apoptotic
- screening
- therapeutic agents
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2510/00—Detection of programmed cell death, i.e. apoptosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- AIDS & HIV (AREA)
- Cardiology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02290578A EP1343013B1 (en) | 2002-03-07 | 2002-03-07 | Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents. |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1343013T3 true DK1343013T3 (da) | 2006-08-21 |
Family
ID=27741248
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02290578T DK1343013T3 (da) | 2002-03-07 | 2002-03-07 | Fremgangsmåder til screening af forbindelser der modulerer apoptose, forbindelser der er identificeret ved fremgangsmåderne, og anvendelse af forbindelserne som terapeutiske midler |
Country Status (13)
Country | Link |
---|---|
US (2) | US7217534B2 (da) |
EP (2) | EP1343013B1 (da) |
JP (1) | JP4414231B2 (da) |
CN (1) | CN100529759C (da) |
AT (1) | ATE324589T1 (da) |
AU (1) | AU2003226678B2 (da) |
CA (1) | CA2478042A1 (da) |
CY (1) | CY1105513T1 (da) |
DE (1) | DE60210919T2 (da) |
DK (1) | DK1343013T3 (da) |
ES (1) | ES2262765T3 (da) |
PT (1) | PT1343013E (da) |
WO (1) | WO2003075015A2 (da) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2881430B1 (fr) * | 2005-02-01 | 2010-10-22 | Servier Lab | Nouveaux peptides interagissant avec les membres anti-apoptotiques de la famille de proteines bcl-2 et utilisations |
WO2007065080A2 (en) * | 2005-11-29 | 2007-06-07 | University Of Maryland, College Park | Control of apoptosis by controlling the propensity of ceramide channel formation |
CN101680886A (zh) * | 2007-03-20 | 2010-03-24 | 沃尔特及伊莱萨霍尔医学研究院 | 筛选方法 |
EP2194783B1 (en) | 2007-08-10 | 2017-07-05 | VM Discovery, Inc. | Compositions and methods for apoptosis modulators |
JP2020524480A (ja) * | 2016-11-03 | 2020-08-20 | セル マイクロシステムズ インクCell Microsystems, Inc. | 特定の数の細胞の自動収集 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3855409A (en) * | 1970-04-01 | 1974-12-17 | Schmid Lab | Method for treating hypercholesterolemia |
JP2002532553A (ja) * | 1998-12-21 | 2002-10-02 | インケイサ.ソシエダ アノニマ | 有害な胃腸副作用を引き起こさない有力な抗炎症剤としてのエーテルリゾリン脂質の使用 |
AU765983B2 (en) * | 1999-05-28 | 2003-10-09 | Apoptosis Technology, Inc. | Compounds and methods for regulating apoptosis, and methods of making and screening for compounds that regulate apoptosis |
AU2460601A (en) * | 1999-12-27 | 2001-07-09 | La Jolla Institute For Allergy | Methods for identifying agents capable of modulating protein kinase c theta (pkctheta) activity |
WO2002066954A2 (en) * | 2001-02-16 | 2002-08-29 | Arbor Vita Corporation | Pdz domain interactions and lipid rafts |
-
2002
- 2002-03-07 DK DK02290578T patent/DK1343013T3/da active
- 2002-03-07 PT PT02290578T patent/PT1343013E/pt unknown
- 2002-03-07 AT AT02290578T patent/ATE324589T1/de active
- 2002-03-07 ES ES02290578T patent/ES2262765T3/es not_active Expired - Lifetime
- 2002-03-07 EP EP02290578A patent/EP1343013B1/en not_active Expired - Lifetime
- 2002-03-07 DE DE60210919T patent/DE60210919T2/de not_active Expired - Lifetime
-
2003
- 2003-03-07 WO PCT/EP2003/002921 patent/WO2003075015A2/en active Application Filing
- 2003-03-07 CN CNB038101785A patent/CN100529759C/zh not_active Expired - Fee Related
- 2003-03-07 AU AU2003226678A patent/AU2003226678B2/en not_active Ceased
- 2003-03-07 EP EP03743394A patent/EP1481250A2/en not_active Withdrawn
- 2003-03-07 CA CA002478042A patent/CA2478042A1/en not_active Abandoned
- 2003-03-07 JP JP2003573423A patent/JP4414231B2/ja not_active Expired - Fee Related
-
2005
- 2005-05-31 US US11/140,275 patent/US7217534B2/en not_active Expired - Fee Related
-
2006
- 2006-07-17 CY CY20061100987T patent/CY1105513T1/el unknown
-
2007
- 2007-04-05 US US11/696,804 patent/US20070184435A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
PT1343013E (pt) | 2006-09-29 |
DE60210919T2 (de) | 2007-05-10 |
AU2003226678B2 (en) | 2009-12-10 |
CN100529759C (zh) | 2009-08-19 |
JP4414231B2 (ja) | 2010-02-10 |
WO2003075015A3 (en) | 2003-12-24 |
ES2262765T3 (es) | 2006-12-01 |
US20060040331A1 (en) | 2006-02-23 |
EP1343013B1 (en) | 2006-04-26 |
CY1105513T1 (el) | 2010-04-28 |
CN1650169A (zh) | 2005-08-03 |
US20070184435A1 (en) | 2007-08-09 |
US7217534B2 (en) | 2007-05-15 |
DE60210919D1 (de) | 2006-06-01 |
AU2003226678A1 (en) | 2003-09-16 |
ATE324589T1 (de) | 2006-05-15 |
WO2003075015A2 (en) | 2003-09-12 |
CA2478042A1 (en) | 2003-09-12 |
EP1481250A2 (en) | 2004-12-01 |
JP2005518813A (ja) | 2005-06-30 |
EP1343013A1 (en) | 2003-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1891020T3 (da) | Fremgangsmåder til fremstilling af azoxystrobin ved brug af DABCO som katalysator og hidtil ukendte mellemprodukter, der anvendes i fremgangsmåderne | |
DK1807504T3 (da) | Serumfrit cellekulturmedium til celler fra pattedyr | |
DK1661278T3 (da) | Forbedret uplink drift ved blöd overlevering | |
SG158141A1 (en) | Pancreatic polypeptide family motifs, polypeptides and methods comprising the same | |
NO20034944D0 (no) | Re-aktiverte T-celler for adoptiv immunoterapi | |
ITRM20030395A0 (it) | Terreno di coltura per il mantenimento, la proliferazione e il differenziamento di cellule di mammifero. | |
WO2007022515A3 (en) | Stem cell derived factors for treating pathologic conditions | |
FR2858410B1 (fr) | Procede de determination des contraintes, deformations, endommagement de pieces constituees d'un materiau solide. | |
CL2008003587A1 (es) | Polipeptido que comprende un epitope inductor de la muerte celular; metodo de produccion de anticuerpos; metodo de identificacion de un compuesto candidato para inducir la muerte de las celulas t activadas. (divisional solicitud n° 1082-05) | |
DE60303898D1 (de) | Apparat zum Betreiben von Gasturbinen | |
DE60331310D1 (de) | Verfahren zum apoptosenachweis | |
EP1401869A4 (en) | MOLECULES AND METHODS FOR PREVENTING KIM-1 RELEASE | |
DK1343013T3 (da) | Fremgangsmåder til screening af forbindelser der modulerer apoptose, forbindelser der er identificeret ved fremgangsmåderne, og anvendelse af forbindelserne som terapeutiske midler | |
NZ551828A (en) | A method of cell isolating a homogenous population of mammary stem cells using specific cell surface marker proteins | |
BR0211506B1 (pt) | tampa para célula eletroquìmica. | |
ATE317461T1 (de) | Dichtungsystem für elektrolysezelle | |
IS7154A (is) | Bv8 kjarnsýrur og fjölpeptíð með mítósu-valdandi verkun | |
GB0220553D0 (en) | Method andapparatus for determining the viability of eggs | |
EA200602261A1 (ru) | Подвижная плита | |
IL158913A0 (en) | Methods for predicting the activities of cellular constituents | |
WO2004096991A3 (en) | Bcl2l12 polypeptide activators and inhibitors | |
AU2003298160A1 (en) | High-throughput screening method for identifying active substances by means of co-cultivation | |
ITBO20040428A1 (it) | Procedimento per il recupero di metatitanato di litio ceramico | |
ITRM20040267A1 (it) | Procedimento informatizzato di controllo per la produzione di ghisa liquida. | |
TWI264956B (en) | Method for performing access point handoff for mobile node |